Form 4 for CRM Salesforce
Accepted 2024-01-23 00:00:00 ET · period of report 2024-01-22 · accession 0001127602-24-001974 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-23 | 2024-01-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $213.97 | +15.2K | 15.2K | New | +$3.25M |
| DM | 2024-01-23 | 2024-01-22+ | CRM | Millham Brian | Pres, COO | S - Sale+OE | $283.91 | -14.8K | 655 | -96% | -$4.20M |
| DM | 2024-01-23 | 2024-01-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $0.00 | -15.2K | 28.2K | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-22 | M | A | 2,106 | $218.21 | 6,524 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-22 | M | A | 655 | $0.00 | 655 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-23 | S | D | 262 | $278.71 | 393 | D | — | — | |
| 4 | Common | Common Stock | 2024-01-22 | M | A | 1,745 | $154.14 | 2,400 | D | — | — | |
| 5 | Common | Common Stock | 2024-01-22 | M | A | 2,018 | $215.17 | 4,418 | D | — | — | |
| 6 | Common | Common Stock | 2024-01-22 | M | A | 8,646 | $240.95 | 15,170 | D | — | — | |
| 7 | Common | Common Stock | 2024-01-22 | S | D | 14,515 | $284.00 | 655 | D | — | — | |
| 8 | Derivative | Restricted Stock Units | 2024-01-22 | M | D | 655 | $0.00 | 655 | D | $0.00 · 2021-04-22 to 2024-04-22 | 655 Common Stock | (F3) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F4) These restricted stock units vest as to 25% of the original grant on April 22, 2021, and vest as to 1/16 of the original grant quarterly thereafter. |
| 9 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-01-22 | M | D | 1,745 | $0.00 | 5,237 | D | $154.14 · 2021-04-22 to 2027-04-22 | 1,745 Common Stock | (F5) Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 10 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-01-22 | M | D | 8,646 | $0.00 | 112,398 | D | $240.95 · 2022-02-22 to 2028-02-22 | 8,646 Common Stock | (F8) Option is exercisable and vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 11 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-01-22 | M | D | 2,106 | $0.00 | 54,774 | D | $218.21 · 2023-03-22 to 2029-03-22 | 2,106 Common Stock | (F7) Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 12 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-01-22 | M | D | 2,018 | $0.00 | 28,250 | D | $215.17 · 2022-03-22 to 2028-03-22 | 2,018 Common Stock | (F6) Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |